Researchers have found that a drug used to treat advanced pancreatic cancer may also be effective in treating another type of cancer. The drug, known by its brand name and a generic name, targets a family of proteins that can contribute to cancer. A study involving 136 patients with a specific type of lung cancer found that tumors shrank in a significant percentage of participants.

The effectiveness of the drug varied by dosage, with higher doses producing better results. This study focused on safety and did not compare the drug to others. Further information about the study and its findings are available.